Outcome of Board Meeting

L1 PLANT &REGD. OFFICE: &= PLOTNO. B-31, M.I.D.C. - MAHAD, TALUKA- MAHAD, DIST. RAIGAD -402 302. MAHARASHTRA. B 09869234017. (=] info@caprolactam.co.in Caprolactam Chemicals Ltd. g CINNo.:L24110MH1988PLC049683 & www.caprolactam.co.in 13" August 2026 The Deputy Manager, Department of Corporate Services, BSE Limited, P.J. Towers, Dalal Street, Fort, Mumbai - 400001. Scrip Code: 507486 (BSE) Subject: Outcome of Board Meeting held on August 13, 2026 Dear Sir, We hereby inform you that, in compliance with Regulation 30 read with Schedule Ill, Regulation 33, Regulation 42 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), the Board of Directors of Caprolactam Chemicals Limited (“the Company”), at their Meeting held today viz. August 13th, 2026, has inter-alia, approved the following: Unaudited Standalone Financial Results for the quarter ended June 30th, 2026: Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a Statement of Unaudited Standalone Financial Results for the quarter ended June 30th, 2026 along with Limited Review Report submitted by the Statutory Auditors of the Company. The above financial results were upon recommendation of the Audit Committee approved by the Board of Directors at its meeting held on August 13th, 2026. The meeting of the Board of Directors of the Company commenced at 12.00 p.m. and concluded at 1:00 p.m. Kindly take the same on your record. We request you to inform your members accordingly. Thanking you. Yours faithfully, For Caprolactam Chemicals Limited Zaver Shankarlal Bhanushali Managing Director DIN: 00663374 PULINDRA PATEL & CO. CHARTERED ACCOUNTANTS O Bf of ri ic vae l N io (. E aA s- t1 )0 , 0 M4, u Pa mra bs a-B u 6is 6i , n ess Center, Near Borivali Station East, Kasturba Road No.1, INDI % EOf mf ai ic le :( T ce al o) c0 e2 @2 2 u8 li0 n6 d9 r6 a6 p4 a, 0 e2 l2 .- c2 o2 m0 56233, 022-68844594, 491 9322268243, Office (M) + 91 9619908533 oI fn d te hp ee n Cd oe mn pt aA nu ydi pt uo rr' ss aR ne tv ti oe tw eR e Rp eo gr ut ao tn ot nh e 3S t oa fn d ta hl o Sn Ee BU In a (u Ld isi tt ie nd Q Ou ba lr it ge ar tl iy nF si n aa nn dc i Da il cR le os su ul rt es Requirements) Regulations, 2015 (as amended) Review Report to The Board of Directors, Caprolactam Chemicals Limited Plot No. B-31, M.LD.C.- Mahad, Taluka — Mahad, Dist. Raigad — 402302. We have | reviewed the quarterly unaudited standalone financial results of M/S.CAPROLACTAM CHEMICALS LIMITED (the company) for the, Quarter ended June 30, 2026 (th# Statement”) attached herewith, being submitted by the company pursuant to the requirement ‘Df Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations 1015 as amended (“Listing Regulations”). This statement which is the responsibility of the Company’s Management and has been reviewed by the Audit committee and approved by the Board of Directors at their respective meetings held on 13" August, 2026, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (Ind AS 34), prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to issue a repor:r[wn the statement based on our review. We conductc%i our review of the Statement in accordance with the standard on Review Engagement FSRE) 2410 ‘Review of Interim Financial Information performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. This standard ‘equires that we plan and perform the review to obtain moderate assurance as to whether the financial statement is free of material misstatements. A review is limited primarily to inquiries o ‘company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with the aforesaid Indian accounting standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended|including the manner in which it is to be disclosed, or that it contains any material misstatement. Attention is|drawn to the fact that the figures for the three months ended 31 March 2025 as reported in the Statement are the balancing figures between audited figures in respect of the full previous financial year and the published year to date figures up to the third quarter of the previous financial year. The figures up to the end of the third Quarter of previous financial year had only been reviewed and not subjected to audit. FOR PULINDRA PATEL & CO. CHARTERED ACCOUNTANTS FIRM REGN. NO. 115187W /{x/l\‘ Place: Munbai Date: 13% August, 2026 PULINDRA PATEL MEMBERSHIP No. 043991 \ UDIN: 26048991 COBH XL Caprolactam Chemicals Limited CIN No. L24110MH1988PLC049683 UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026 PART | (Rs. In Lakhs) PARTICULARS Quarter Ended Year Ended (Unaudited) (Audited) (Unaudited) | (Audited) 30-06-2026 31-03-2026 30-06-2025 31-03-2026 1_| Revenue From Operetion Revenue from Operations 46.77 306.70 25647 1.055.75 [Other Income 0.09 0.70 0.09 3.1 Total Income 46.86 307.40 1,058.86 2 | Expenses (a) [Cost of materials consumed 0.78 9.76) 2941 73.43 (b) |Purchase of stock - I trade 24.42 0.90 493 1130 (e Chane in inventoris ofF inished goods, work-in-progress and stock- 5 = 375 375 intrade (d) |[Employee benefits expenses 922 17.29 1127 51.63 (e) JFinance Costs 17.76 17.23 18.25 7191 (D Depreciation, depletion and amortisation expenses 36.71 43.77 38.02 161.41 (g) |Other expenses 56.85 113.37 10238 468.87 Total Expenses| 145.74 202.32 208.01 842.29 3 | Profit / (Loss) before_tax (1-2) (98.88)) 105.08 48.55 216.57 4 |Tax Expense 1 Current tax = 19.96 37.35 Defered tax (0.02) 136 3.09 Total Tax Expenses| (0.02) 21.32 40.44 5_|Total Profit/(loss) After Tax (3-4) (98.86) 83.76 176. 6 _|Other Comprehensive Income (OCI) - - a) Items That Will Not Be Reclassified To Profit or Loss (0.83) (0.83) b) Items That Will Be Reclassified To Profit or Loss - - ¢ 8 Total Comprehensive Income/(Loss) for the period (5+6)] (98.86)} 82.93] 175.29) 8 |Details of equity share capital 9 |Paid-up cquity share capital 460.00 360.00 460.00 460.00 [Face value of equity share capital 10.00 10.00 10.00 10.00 10 [Other Equity 11 [Earnings per share 12 [Earnings per equity share Rs. [Basic (2.15) 1.82 0.79 3.83 Diluted (2.15)] 1.82 0.79 3.83 13 |Nominal value of share 10.00 10.00 10.00 10.00 [Disclosure of notes on finance results 1. The above results were reviewed by the Audit Committee and approved by the Board of Directors at their respective mectings held on 13(h [A ugust, 2026 and have been subjected to limited review by the Auditors. 2) These financial results of the Company have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. 3) The Standalone results of the compnay are available on the company's website http://caprolactum.co.in/and also available on the websites of the BSE Ltd. And National Stock Exchange of India Ltd. ) Figures for the previous quarter/ period have been regrouped/reclassified, wherever considered necessary.Figures [Showing first 8,000 characters — download PDF for full document]